Two sides of management recommendations for psoriatic arthritis

IF 29.4 1区医学 Q1 RHEUMATOLOGY

Nature Reviews Rheumatology Pub Date : 2024-05-21 DOI:10.1038/s41584-024-01127-3

Ennio Lubrano, Fabio Massimo Perrotta

引用次数: 0

Abstract

Guidelines for the management of psoriatic arthritis (PsA) need to undergo revision to take on board new evidence, particularly in relation to therapeutics. In March 2024, EULAR published updated recommendations for the pharmacological treatment of PsA, and an expert group published consensus statements intended to complement existing guidelines.

查看原文本刊更多论文

银屑病关节炎管理建议的两面性

银屑病关节炎（PsA）的治疗指南需要进行修订，以采纳新的证据，尤其是与治疗有关的证据。2024 年 3 月，EULAR 发布了 PsA 药物治疗的最新建议，一个专家小组也发布了旨在补充现有指南的共识声明。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Nature Reviews Rheumatology 医学-风湿病学

CiteScore

29.90

自引率

0.90%

发文量

137

审稿时长

6-12 weeks

期刊介绍： Nature Reviews Rheumatology is part of the Nature Reviews portfolio of journals. The journal scope covers the entire spectrum of rheumatology research. We ensure that our articles are accessible to the widest possible audience.